rTMS is FDA approved for treatment-resistant depression. Overseas, it is approved for chronic pain, migraine, and obsessive-compulsive disorder. rTMS is the subject of intensive research and has shown significant benefit for a number of conditions, including complex regional pain syndrome, neuropathic pain, spinal pain, and migraine. It has also been successfully used for the treatment of addiction, post-traumatic stress disorder, and traumatic brain injury, and it has been studied for use in such conditions as Alzheimer’s disease and multiple sclerosis.
The latest research indicates when combined, theta-burst stimulation and ketamine infusions may help some of the most . is now FDA approved for migraine. Repetitive transcranial magnetic stimulation has been shown to be clearly effective for chronic migraine and has been shown to be beneficial for complex regional pain syndrome (CRPS). In the United States, most insurance carriers will cover the cost of treatment for rTMS for treatmentresistant major depression.